BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 551087)

  • 1. [Assay of cefaclor in serum and urine (including stability test) using high pressure liquid chromatography (author's transl)].
    Harhausen E; Simon C
    Infection; 1979; 7 Suppl 6():603-5. PubMed ID: 551087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thin layer and high pressure liquid chromatography investigations with cefaclor in urine and serum (author's transl)].
    Ullmann U; Diekmann HW
    Infection; 1979; 7 Suppl 6():554-6. PubMed ID: 399248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
    Lode H; Köppe P; Stahlmann R
    Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
    Lode H; Stahlmann R; Dzwillo G; Koeppe P
    Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cefaclor by high-performance liquid chromatography.
    Nahata MC
    J Chromatogr; 1982 Mar; 228():429-33. PubMed ID: 7076773
    [No Abstract]   [Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of loracarbef, a potential metabolite, cefaclor and cephalexin in human plasma, serum and urine.
    Kovach PM; Lantz RJ; Brier G
    J Chromatogr; 1991 Jun; 567(1):129-39. PubMed ID: 1918240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigations on the excretion of cefaclor in human bile (author's transl)].
    Müller O; Rückert U; Fabricius K
    Infection; 1979; 7 Suppl 6():624-7. PubMed ID: 551091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique.
    Rotschafer JC; Crossley KB; Lesar TS; Zaske D; Miller K
    Antimicrob Agents Chemother; 1982 Jan; 21(1):170-2. PubMed ID: 7081972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and sputum levels of cefaclor.
    Simon C; Gatzemeier U
    Postgrad Med J; 1979; 55 Suppl 4():30-4. PubMed ID: 548940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cefaclor oral suspensions stability using reversed phase high performance liquid chromatography and antimicrobial diffusion methods.
    Tarawneh KA; Halasah ZA; Khleifat AM; Batarseh MI; Khleifat KM; Al-Mustafa AH
    Pak J Pharm Sci; 2011 Jul; 24(3):303-13. PubMed ID: 21715263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-pressure liquid chromatography and microbiological assay in the determination of serum levels using cefradine and cefaclor.
    Ullmann U
    Zentralbl Bakteriol A; 1980; 248(3):414-21. PubMed ID: 6784388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Subinhibitory activity of cefaclor and cephalexin (author's transl)].
    Shah PM; Staszewski S
    Infection; 1979; 7 Suppl 6():543-6. PubMed ID: 399246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cefaclor and cephradine in serum by ion-pair reversed-phase chromatography.
    Lindgren K
    J Chromatogr; 1987 Jan; 413():351-4. PubMed ID: 3558691
    [No Abstract]   [Full Text] [Related]  

  • 14. Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
    McAteer JA; Hiltke MF; Silber BM; Faulkner RD
    Clin Chem; 1987 Oct; 33(10):1788-90. PubMed ID: 3665031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum and tissue concentrations after a single dose of cefaclor].
    Plaue R; Müller O; Fabricius K; Bethke RO
    Infection; 1979; 7(5):252-5. PubMed ID: 511343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefaclor dosage change with renal dysfunction].
    Usuda Y; Sekine O
    Jpn J Antibiot; 1985 Apr; 38(4):1141-6. PubMed ID: 4032725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis.
    Spyker DA; Gober LL; Scheld WM; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1982 Feb; 21(2):278-81. PubMed ID: 7073265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semi-quantitative analysis of cefaclor in human serum by capillary high performance liquid chromatography/fast atom bombardment mass spectrometry.
    Sato K; Kobayashi K; Moore CM; Mizuno Y; Katsumata Y
    Forensic Sci Int; 1993 Apr; 59(1):71-7. PubMed ID: 8505030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefaclor in patients with stable renal impairment, and patients undergoing haemodialysis.
    Gartenberg G; Meyers BR; Hirschmann SZ; Srulevitch E
    J Antimicrob Chemother; 1979 Jul; 5(4):465-70. PubMed ID: 489494
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cefaclor in the treatment of upper respiratory tract bacterial infections in children. A comparative trial of cefaclor/cefalexin (author's transl)].
    Leveque B; Lambert-Zechovsky N; Cathlin C
    Ann Pediatr (Paris); 1980 Jun; 27(6):405-8. PubMed ID: 7013629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.